A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

NCT00418600 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG: Hectorol® (doxercalciferol capsules)
DRUG: doxercalciferol capsules, Hectorol®
DRUG: doxercalciferol capsules, Hectorol® capsules

Sponsor

Genzyme, a Sanofi Company